Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes

Published:2013-05-30 Issue:7 Volume:88 Page:566-570
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Mishra Asmita¹,Corrales-Yepez Maria¹,Ali Najla Al¹,Kharfan-Dabaja Mohamed¹,Padron Eric¹,Zhang Ling¹,Epling-Burnette Pearlie K.¹,Pinilla-Ibarz Javier¹,Lancet Jeffrey E.¹,List Alan F.¹,Komrokji Rami S.¹

Affiliation:

1. H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23454/fullpdf

Reference16 articles.

1. Myelodysplastic syndromes classification and risk stratification;Komrokji;Hematol Oncol Clin North Am,2010

2. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

3. NCCN Clinical Practice Guidelines in Oncology Myelodysplastic Syndromes (Version 2, 2013) www.nccn.org/professionals/physician_gls/f_guidelines.asp#mds

4. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic cell transplantation (HCT) in MDS patients of older age;Leukemia & Lymphoma;2024-02-05

2. When to use which molecular prognostic scoring system in the management of patients with MDS?;Best Practice & Research Clinical Haematology;2023-12

3. Are We Ready For “Triplet” Therapy in Higher-Risk MDS?;Clinical Hematology International;2023-11-03

4. Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS);Blood Reviews;2023-11

5. Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study;Leukemia Research;2023-10